TY - JOUR
T1 - Reclassifying insulins
AU - Feher, Michael D.
AU - Bailey, Clifford J.
PY - 2004/1/1
Y1 - 2004/1/1
N2 - Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-regimens, a new, simple, pragmatic classification is suggested in which insulin are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).
AB - Insulins have hitherto been distinguished as clear (short-acting) and cloudy (long-acting). However the introduction of glargine, which is clear long-acting insulin, has prompted the need for reclassification. In view of the increasing emphasis on intensive insulin therapy using basal-regimens, a new, simple, pragmatic classification is suggested in which insulin are categorised according to the timing and purpose of administration: basal (maintenance), bolus (meal) and biphasic (mixed).
KW - Basal insulins
KW - Biphasic insulins
KW - Bolus insulins
KW - Insulin
UR - http://www.scopus.com/inward/record.url?scp=1542360024&partnerID=8YFLogxK
UR - https://journals.sagepub.com/doi/pdf/10.1177/14746514040040010701
U2 - 10.1177/14746514040040010701
DO - 10.1177/14746514040040010701
M3 - Article
AN - SCOPUS:1542360024
SN - 1474-6514
VL - 4
SP - 39
EP - 42
JO - British Journal of Diabetes and Vascular Disease
JF - British Journal of Diabetes and Vascular Disease
IS - 1
ER -